To: Jack Hartmann who wrote (87049 ) 5/7/2003 4:38:37 PM From: 2MAR$ Respond to of 208838 I see VRTS got downgraded to sell by ...." Punk, Ziegel & Co" with trgt of $18 ... Now not really sure of who these PunK & Ziegle guys are ...maybe time to start following the performance of these "next-generation" post bubble analysts , and see how they do. VRTS was good trade on the long side after earns , don;t mind shorting it again when the time comes . They have been pumping this VXGN looks like , but it hasn't done too well so far :stockcharts.com [h,a]daclyyay[pb50!b200][vc60][iUc20!La12,26,9]&pref=G Seems PUNK & ZIEG are mostly into genomics , pharmies and proteinomics , and they are downgrading VRTS ? Kind of off the beaten path for them it would seem ...maybe some of Robbie Stephens p & d people wound up over there ?<G> website of Punk & Zieglerpzk.com Punk, Ziegel & Company is an investment banker to sophisticated investors and innovative companies in the Technology and Healthcare sectors we serve. Our focus industries include Internet and Information Technology Services, Life Sciences, Healthcare Internet, telecommunications and Enterprise Software. Transactions: VaxGen, Inc. -- Co-manager of $46.3 million IPO Conduit Communications Limited -- Financial advisor in sale to International Integration Inc. (i-Cube) Genomica Corporation -- Sole manager of $13.6 million private placement Lexicon Genetics -- Sole manager of $31.8 million private placement BioNumerik Pharmaceuticals -- Co-manager of $15.4 million private placement CytoMed -- Sole manager of $19.1 million private placement PRT Group, Inc. -- Co-manager of $61.6 million IPO Lynx Therapeutics, Inc. -- Sole manager of $26.8 million private placement Computer Horizons Corp. -- Co-manager of $106.5 million secondary offering